Radiopharmaceutical usage at record levels
Tuesday, 02 October, 2001
Demand for radiopharmaceuticals produced by the Australian Nuclear Science and Technology Organisation grew to record levels during the last financial year with a 13% increase in sales.
Most of the radiopharmaceuticals were produced from the operation of ANSTO's HIFAR research reactor. The result confirms that applications of nuclear medicine are expanding, and that most Australians will use an ANSTO radiopharmaceutical product at some time in their lifetime for the diagnosis or treatment of disease.
Item provided courtesy of Science Industry
AXT to distribute NT-MDT atomic force microscopes
Scientific equipment supplier AXT has announced a partnership with atomic force microscope (AFM)...
Epigenetic patterns differentiate triple-negative breast cancers
Australian researchers have identified a new method that could help tell the difference between...
Combined effect of pollutants studied in the Arctic
Researchers from the Fram Centre in Norway are conducting studies in Arctic waters to determine...
